SCHEMBL840596

SCHEMBL840596

O=Cc1ccc(-c2cccc(CN3CCCCC3)n2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
CXCR4 P61073 2/20 0.39
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
DYRK1A Q13627 1/20 0.38
ACP1 P24666 2/20 0.38
FFAR4 Q5NUL3 2/20 0.37
SCN9A Q15858 1/20 0.37
ALDH1A3 P47895 2/20 0.36
FLT3 P36888 1/20 0.35
TYRO3 Q06418 1/20 0.35
MERTK Q12866 1/20 0.35
GAS6 Q14393 1/20 0.35
PARP1 P09874 1/20 0.35
HTT P42858 1/20 0.35
ERN1 O75460 1/20 0.35
KDM4E B2RXH2 1/20 0.35
JAK2 O60674 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL838858 0.83 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2CLK2CLK3DYRK1A
SCHEMBL839479 0.80 CYP2D6 (0.42) ALDH1A1SMN1; SMN2CXCR4SCN9APARP1
SCHEMBL840636 0.76 ACP1 (0.39) ALDH1A1ACP1SCN9AFLT3TYRO3
SCHEMBL839660 0.75 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2CXCR4CLK2CLK3
SCHEMBL18157904 0.70 CXCR4 (0.66) ALDH1A1SMN1; SMN2CXCR4HTTKDM4E
SCHEMBL8305165 0.70 CXCR4 (0.49) ALDH1A1SMN1; SMN2CXCR4ERN1KDM4E
SCHEMBL31497604 0.70 KIF11 (0.40) ALDH1A1SMN1; SMN2
Bromide SCHEMBL29605492 0.69 CXCR4 (0.63) ALDH1A1SMN1; SMN2CXCR4HTTKDM4E
Hydrochloric Acid SCHEMBL29604003 0.69 CXCR4 (0.63) ALDH1A1SMN1; SMN2CXCR4HTTKDM4E
SCHEMBL31193388 0.69 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2ALDH1A3HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143246-B2 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives MSD OSS B.V. (NL) 2012-03-27 US disclosed
US-20100144724-A1 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES N.V.ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144724-A1 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES OPRD1, CNR1, CNR2 ALDH1A1 3782/4885SMN1; SMN2 87/4885CXCR4 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.